OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Alison Goate

1 Projects | 1 Researchers | $598,982 Invested

2025

Icahn School of Medicine at Mount Sinai

Alison Goate, D.Phil.

Development of a Scalable CSF YWHAG:NPTX2 ELISA Assay for Cognitive Prognosis in Early AD

  • Funding Amount: $598,982
  • Organization Type:
  • Program: Biomarkers
  • Status: Active